-
Hikma Pharma Says Not Signed Licensing Agreement With Opiant Pharma
来源: NASDAQ US Markets / 29 4月 2022 23:58:14 America/New_York
(RTTNews) - Hikma Pharmaceuticals plc. (HIK, HIK.L) said Friday that it has not entered into any transaction with Opiant Pharmaceuticals (OPNT), contrary to a PR Newswire announcement issued today indicating that Opiant Pharmaceuticals and Hikma have entered into a commercialisat https://www.nasdaq.com/articles/hikma-pharma-says-not-signed-licensing-agreement-with-opiant-pharma